Tomita Y, Nomoto K
Division of Cardiovascular Surgery, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Immunobiology. 1992 Nov;186(3-4):282-91. doi: 10.1016/S0171-2985(11)80257-3.
Transfusion with allogeneic cells alone was reported to prolong skin allograft survival in the MHC class I antigen alone-disparate combination of B6.C-H-2bm1 (bm1; Kbm1, IAb, IE-, Db)-->C57BL/6 CrSlc (B6; H-2b). Using 6 class I antigen-disparate and 2 class II antigen-disparate combinations, we compared the effectiveness for skin graft prolongation between transfusion with donor cells (TDC) and our system of CP-induced tolerance, which comprises intravenous (i.v.) injection of allogeneic cells followed by cyclophosphamide (CP), i.e., TDC followed by CP. TDC was effective only in the combination of bm1-->B6, but not at all in the other combinations. On the other hand, CP-induced tolerance was effective in the 5 class I antigen-disparate and 2 class II antigen-disparate combinations except for bm1-->B6 combination. These results suggest that CP-induced tolerance may be more general for the induction of unresponsiveness than TDC.
据报道,单独输注同种异体细胞可延长皮肤移植在仅MHC I类抗原不同的B6.C-H-2bm1(bm1;Kbm1、IAb、IE-、Db)与C57BL/6 CrSlc(B6;H-2b)组合中的存活时间。使用6种I类抗原不同和2种II类抗原不同的组合,我们比较了输注供体细胞(TDC)和我们的环磷酰胺诱导耐受系统(包括静脉注射同种异体细胞后给予环磷酰胺,即TDC后给予CP)在延长皮肤移植存活方面的效果。TDC仅在bm1→B6组合中有效,在其他组合中完全无效。另一方面,环磷酰胺诱导的耐受在除bm1→B6组合外的5种I类抗原不同和2种II类抗原不同的组合中有效。这些结果表明,与TDC相比,环磷酰胺诱导的耐受在诱导无反应性方面可能更具普遍性。